Formulation and Evaluation of Venlafaxine Sustained-Release Tablets for Improved Patient Compliance: A Comprehensive Review

Authors

  • Singh Anuj Kumar
  • Mujahid Mohd

Keywords:

Venlafaxine, Sustained-release, Patient Compliance, Formulation, Evaluation, Depression, Anxiety Disorders.

Abstract

The prevalence of major depressive disorder and anxiety disorders has highlighted the need for more effective and patient-friendly therapeutic approaches. Among these, Venlafaxine, a serotonin-nor epinephrine reuptake inhibitor (SNRI), is an often prescribed medication. However, its twice-daily dosage regimen can be inconvenient, leading to non-compliance. To address this issue, the development of sustained-release formulations of Venlafaxine is becoming increasingly relevant. This review paper comprehensively discusses the formulation and evaluation of Venlafaxine sustained-release tablets, with an emphasis on how this approach may enhance patient compliance.

Downloads

Published

2023-08-18

Issue

Section

Articles

How to Cite

Formulation and Evaluation of Venlafaxine Sustained-Release Tablets for Improved Patient Compliance: A Comprehensive Review. (2023). International Journal of Research Development and Technology, 1(1). http://ijrdt.com/index.php/files/article/view/86